Collectively, these data are the first to demonstrate that ChemR23 activation improves neuronal pyroptosis in CCH via the PI3K/AKT/Nrf2 pathway, indicating that ChemR23 can serve as an important target for treating CCH-induced VaD (Fig. 9). Here, AKT1 is linked to columnar cell hyperplasia of the breast.